Chugai Pharmaceutical Co.... (CHGCY)
OTC: CHGCY
· Real-Time Price · USD
21.28
0.49 (2.36%)
At close: Aug 15, 2025, 3:59 PM
21.25
-0.12%
After-hours: Aug 15, 2025, 04:00 PM EDT
Chugai Pharmaceutical Cash Flow Statement
Financials in JPY. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 397.49B | 398.33B | 436.21B | 506.72B | 492.82B | 488.49B | 575.88B | 569.25B | 596.34B | 596.51B | 470.37B | 398.91B | 362.48B | 331.63B |
Depreciation & Amortization | 2.3B | 2.7B | 2.8B | 1.8B | 2B | 1.9B | 1.7B | 3.2B | 3.1B | 4B | 3.7B | 31.98B | 31.58B | 30.38B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 114.85B | 50.55B | 130.63B | -80.98B | -75.84B | -25.96B | -183.31B | -46.09B | -48.13B | -156.45B | -13.43B | -126.76B | -16.23B | 88.07B |
Other Non-Cash Items | -185.56B | -66.48B | -159.36B | -168.82B | -166.37B | -165.12B | -149.85B | -157.89B | -125.96B | -134.44B | -107.62B | -112.16B | -93.88B | -95.6B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 114.85B | 50.55B | 130.63B | -80.98B | -75.84B | -25.96B | -183.31B | -46.09B | -48.13B | -156.45B | -83.12B | -29.86B | -15.94B | 10.54B |
Operating Cash Flow | 328.28B | 384.3B | 410.28B | 258.71B | 252.6B | 299.32B | 244.11B | 366.07B | 422.55B | 305.63B | 279.63B | 256.89B | 252.66B | 246.57B |
Capital Expenditures | -62.36B | -59.6B | -74.26B | -68.05B | -67.6B | -61.64B | -71.24B | -67.08B | -83.31B | -77.76B | -72.87B | -76.02B | -58.26B | -80.99B |
Cash Acquisitions | 17.41B | 17.09B | 18.79B | 1.35B | 1.27B | 2.74B | 1.05B | 1.11B | 3.57B | 3.91B | 6.86B | 8.15B | 6.48B | 6.07B |
Purchase of Investments | -742.47B | -569.38B | -545.98B | -545.19B | -572.49B | -565.62B | -519B | -488.33B | -409.62B | -382.24B | -372.26B | -343.18B | -353.16B | -290.34B |
Sales Maturities Of Investments | 619.27B | 574.54B | 546.96B | 530.09B | 507.93B | 462.05B | 442.92B | 412.95B | 372.8B | 352.8B | 325.03B | 274.99B | 242.99B | 242.99B |
Other Investing Acitivies | -18.27B | -17.98B | 16.77B | 16.85B | 16.49B | 15.08B | 280M | 211M | -2.29B | -2.72B | -5.68B | -6.94B | -5.28B | -5.96B |
Investing Cash Flow | -166.55B | -35.45B | -37.73B | -64.95B | -114.39B | -147.38B | -145.99B | -141.15B | -118.86B | -106.01B | -118.93B | -143B | -167.23B | -128.23B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -3M | -2M | n/a | -4M | -4M | -5M | -5M | -5M | -5M | -5M | -8M | -9M | -12M | -24M |
Dividend Paid | -131.28B | -131.19B | -131.59B | -131.65B | -128.3B | -128.43B | -138.22B | -138.12B | -125.07B | -124.75B | -98.64B | -98.54B | -90.4B | -90.39B |
Other Financial Acitivies | -8.03B | -7.9B | -7.95B | -7.91B | -7.87B | -7.84B | -7.66B | -8.37B | -8.46B | -8.54B | -8.76B | -8.26B | -8.29B | -8.42B |
Financial Cash Flow | -139.07B | -138.84B | -139.25B | -139.39B | -135.98B | -136.05B | -145.64B | -146.27B | -133.33B | -133.15B | -107.41B | -106.75B | -98.6B | -98.66B |
Net Cash Flow | 28.75B | 215.18B | 236.5B | 57.3B | 4.71B | 17.21B | -45.58B | 81.53B | 173.18B | 68.42B | 55.42B | 9.81B | -9.47B | 23.34B |
Free Cash Flow | 265.92B | 324.7B | 336.02B | 190.66B | 185.01B | 237.68B | 172.87B | 298.99B | 339.24B | 227.87B | 206.76B | 180.87B | 194.4B | 165.58B |